E7820(ER68203-00)是一种口服活性芳香磺酰胺衍生物,是一种独特的血管生成抑制剂,可抑制内皮细胞上整合素α2亚基的表达。E7820以IC50为0.11 μg/ml抑制大鼠主动脉血管生成,调节α-1、α-2、α-3和α-5整合素的mRNA表达,具有抗血管生成和抗肿瘤活性。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Integrin ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tirofiban | ✔ | 99%+ | |||||||||||||||||
ATN-161 | ✔ | 98% | |||||||||||||||||
RGD | ✔ | 98% | |||||||||||||||||
A-205804 |
++
E-selectin, IC50: 20 nM ICAM-1, IC50: 25 nM |
98% | |||||||||||||||||
SB-273005 |
++++
αvβ5 receptor, IC50: 0.3 nM αvβ3 receptor, IC50: 1.2 nM |
98+% | |||||||||||||||||
Lifitegrast | ✔ | 97% | |||||||||||||||||
Cilengitide TFA |
+++
αvβ5 receptor, IC50: 79 nM αvβ3 receptor, IC50: 4.1 nM |
99%+ | |||||||||||||||||
Cyclo(-RGDfK) TFA | ✔ | 99%+ | |||||||||||||||||
Cyclo(RGDyK) trifluoroacetate |
++
αVβ3 integrin, IC50: 20 nM |
99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
产品名称 | Potassium Channel ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tolbutamide | ✔ | 98% | |||||||||||||||||
Glimepiride |
++++
SUR1, IC50: 5.4 nM SUR2B, IC50: 7.3 nM |
97% | |||||||||||||||||
Dronedarone Hydrochloride | ✔ | 95% | |||||||||||||||||
Gliquidone |
++
Potassium channel, IC50: 27.2 nM |
98% | |||||||||||||||||
TRAM-34 |
+++
IKCa1 (KCa3.1), Kd: 20 nM |
98% | |||||||||||||||||
Glibenclamide | ✔ | 98% | |||||||||||||||||
Amiodarone HCl | ✔ | 97% | |||||||||||||||||
Gliclazide |
++
Potassium channel, IC50: 184 nM |
98% | |||||||||||||||||
Repaglinide | ✔ | 98% | |||||||||||||||||
Dofetilide | ✔ | 98% | |||||||||||||||||
Nateglinide | ✔ | 99% | |||||||||||||||||
Quinine hydrochloride dihydrate | ✔ | 98% | |||||||||||||||||
ML133 HCl |
+
Kir2.1, IC50: 290 nM |
97% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | E7820 (ER68203-00), an orally active aromatic sulfonamide derivative, is a unique angiogenesis inhibitor that suppresses the expression of the integrin alpha2 subunit on endothelial cells. It inhibits angiogenesis in rat aorta with an IC50 of 0.11 µg/ml and affects the expression of α-1, α-2, α-3, and α-5 integrin mRNA. E7820 displays antiangiogenic and antitumor activity[1][2]. |
体内研究 | E7820 (ER68203-00) administered at 50-200 mg/kg, orally twice daily for 14 days, delays the growth of subcutaneously inoculated WiDr cells[1]. E7820, given at 200-400 mg/kg orally once daily for four days, strongly inhibits angiogenesis induced by WiDr cells[1]. |
体外研究 | E7820 inhibits both bFGF- and VEGF-driven tube formation in human umbilical vascular endothelial cells (HUVEC) in a dose-dependent manner with IC50 values of 0.20 µg/ml and 0.24 µg/ml, respectively[1]. E7820 suppresses HUVEC proliferation induced by bFGF or VEGF in serum-free medium (SFM), with IC50 values of 0.10 and 0.081 μg/ml, respectively. Compared to its effect on HUVEC, E7820 demonstrates minimal antiproliferative activity against WiDr and LoVo cells, with IC50 values of 29 and 15 μg/ml, respectively[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.97mL 0.59mL 0.30mL |
14.86mL 2.97mL 1.49mL |
29.73mL 5.95mL 2.97mL |
CAS号 | 289483-69-8 |
分子式 | C17H12N4O2S |
分子量 | 336.368 |
别名 | ER68203-00 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,2-8°C |
溶解度 |
DMSO: 105 mg/mL(312.16 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |